Matches in Wikidata for { <http://www.wikidata.org/entity/Q84877733> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q84877733 description "artículu científicu espublizáu n'avientu de 2009" @default.
- Q84877733 description "scientific article published on 01 December 2009" @default.
- Q84877733 description "wetenschappelijk artikel" @default.
- Q84877733 description "наукова стаття, опублікована в грудні 2009" @default.
- Q84877733 name "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 name "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 type Item @default.
- Q84877733 label "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 label "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 prefLabel "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 prefLabel "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 P1433 Q84877733-8C493D79-BC83-4C28-AD0D-064BDD4F1C5E @default.
- Q84877733 P1476 Q84877733-F3E9C276-413E-4C56-A905-A5CD744F7777 @default.
- Q84877733 P2093 Q84877733-6EC16DA9-BE1B-464F-8495-BE948074583A @default.
- Q84877733 P2860 Q84877733-0B71069C-555F-4096-B8F2-704677CAF0E7 @default.
- Q84877733 P2860 Q84877733-1A946651-9C8B-478D-AAE3-03722256C0DF @default.
- Q84877733 P2860 Q84877733-1C7E65A5-6642-4FA1-98B2-C12F146B892D @default.
- Q84877733 P2860 Q84877733-1EFCB581-E232-4ED0-8DB4-33BA601F3E91 @default.
- Q84877733 P2860 Q84877733-2CA1B3C9-EBAB-454A-82AC-E50F110AB090 @default.
- Q84877733 P2860 Q84877733-5B16735F-9123-457C-BF0A-E9BE7B8E81A0 @default.
- Q84877733 P2860 Q84877733-8F2ADEFF-1409-457B-8798-16548132A713 @default.
- Q84877733 P2860 Q84877733-A2A9C1CC-678D-4DAA-B3AE-FC04948C804B @default.
- Q84877733 P2860 Q84877733-AD79E10A-F305-4D98-A472-9335471E37E9 @default.
- Q84877733 P2860 Q84877733-B9710415-32F4-4290-8363-E73207997C2A @default.
- Q84877733 P2860 Q84877733-D1F920D9-567F-4CA8-A44D-1CE9C930DA63 @default.
- Q84877733 P2888 Q84877733-022506D8-3B22-42D9-877E-FB5C73F37BF8 @default.
- Q84877733 P304 Q84877733-8BC5955F-D7AD-4DCC-BA0E-1E35B4B36720 @default.
- Q84877733 P31 Q84877733-D5AE5760-9326-4DB3-AEB2-90CD6ECF3BD1 @default.
- Q84877733 P356 Q84877733-4410810C-EF91-4163-8210-BC42D6A88446 @default.
- Q84877733 P433 Q84877733-C4F27DD5-BED2-4204-BDE1-20971895AE18 @default.
- Q84877733 P478 Q84877733-E2B55333-5EF7-4113-805B-E39F0D57E1E3 @default.
- Q84877733 P577 Q84877733-45AC6BA7-7EA4-4D8E-9CC8-342E8562D3FB @default.
- Q84877733 P6179 Q84877733-E2B04D98-A163-405F-90A5-CB6FF75B8174 @default.
- Q84877733 P698 Q84877733-2D828676-392B-4DB7-AE5C-1CAEAA383F6C @default.
- Q84877733 P356 S11894-009-0066-7 @default.
- Q84877733 P698 19903417 @default.
- Q84877733 P1433 Q26842032 @default.
- Q84877733 P1476 "Do COX-2 inhibitors reduce metachronous cancer development?" @default.
- Q84877733 P2093 "Joseph R Pisegna" @default.
- Q84877733 P2860 Q40483280 @default.
- Q84877733 P2860 Q44490337 @default.
- Q84877733 P2860 Q45256209 @default.
- Q84877733 P2860 Q46531988 @default.
- Q84877733 P2860 Q46594631 @default.
- Q84877733 P2860 Q46788696 @default.
- Q84877733 P2860 Q50471112 @default.
- Q84877733 P2860 Q53411726 @default.
- Q84877733 P2860 Q79611088 @default.
- Q84877733 P2860 Q79993273 @default.
- Q84877733 P2860 Q80938037 @default.
- Q84877733 P2888 s11894-009-0066-7 @default.
- Q84877733 P304 "429-430" @default.
- Q84877733 P31 Q13442814 @default.
- Q84877733 P356 "10.1007/S11894-009-0066-7" @default.
- Q84877733 P433 "6" @default.
- Q84877733 P478 "11" @default.
- Q84877733 P577 "2009-12-01T00:00:00Z" @default.
- Q84877733 P6179 "1011412691" @default.
- Q84877733 P698 "19903417" @default.